The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients-Reference-Cited by-同舟云学术

The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients

Published:2013-08-22 Issue:8 Volume:8 Page:e72784
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Snedecor Sonya J.,Khachatryan Alexandra,Nedrow Katherine,Chambers Richard,Li Congyu,Haider Seema,Stephens Jennifer

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference67 articles.

1. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel;JAMA,2012

2. European AIDS Clinical Society (EACS) guidelines,2012

3. uidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,2011

4. Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1;R Corbau;Antimicrob Agents Chemother,2010

5. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors;J Ghosn;AIDS Res,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are the determinants of antiretroviral therapy adherence among stable people living with HIV? A cross-sectional study in Cambodia;AIDS Research and Therapy;2023-07-14

2. Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients;Antiviral Therapy;2021-05

3. Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV;Current Infectious Disease Reports;2021-04-02

4. Antiretroviral Therapy – Nucleoside/Nucleotide and Non-Nucleoside Reverse Transcriptase Inhibitors;Encyclopedia of Virology;2021

5. Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection;AIDS;2020-08-08